%0 Journal Article
%T Chronic Inflammatory Rheumatic Diseases in Rheumatological Practice in Lomé (Togo)
%A Kodjo Kakpovi
%A Sadat Oniankitan
%A Komi C. Tagbor
%A Koulouktsoa Kondian
%A Viwal¨¦ ES Koffi-Tessio
%A Awaki-Esso Atake
%A Lamine Mamadou Diallo
%A Pahimi Yibe
%A Erika Djougnwe Mba
%A Moubarak Tiadjeri
%A Eyram Fianyo
%A Pr¨¦nam Houzou
%A Owonayo Oniankitan
%A Moustafa Mijiyawa
%J Open Journal of Rheumatology and Autoimmune Diseases
%P 9-20
%@ 2164-005X
%D 2022
%I Scientific Research Publishing
%R 10.4236/ojra.2022.121002
%X Chronic inflammatory rheumatism is a pathology of
variable frequency and severity with a significant impact on the
socio-economic, personal and family </span><span><span style=\"font-family:Verdana;\">level. </span><b><span style=\"font-family:Verdana;\">Study</span></b> <b><span style=\"font-family:Verdana;\">Aim</span></b><span style=\"font-family:Verdana;\">: To describe the epidemiological, clinical, laboratory, r</span></span><span style=\"font-family:Verdana;\">adiological,
therapeutic and evolutive features of chronic inflammatory rheumatic diseases
in rheumatological practice in Togo. </span><b><span style=\"font-family:Verdana;\">Patients</span></b> <b><span style=\"font-family:Verdana;\">and</span></b> <b><span style=\"font-family:Verdana;\">Methods</span></b><span style=\"font-family:Verdana;\">:
This was a multicenter cross-sectional study conducted from January 2011 to
December 2019 on patients examined in the three rheumatology departments in
Lom¨¦ (Togo). Patients 18 years old and above who have presented joint pain </span><span style=\"font-family:Verdana;\">with or without synovitis, and/or rachialgia
(back pain) for at least three m</span><span style=\"font-family:Verdana;\">onths were included. The diagnosis of
chronic inflammatory rheumatic diseases was made according to international
consensus criteria. </span><b><span style=\"font-family:Verdana;\">Results</span></b><span style=\"font-family:Verdana;\">: Out of the 20333 patients whose files were
collected during our study period, 290 (1.43%) suf</span><span style=\"font-family:Verdana;\">fered from chronic inflammatory rheumatic diseases. There were 226 (</span><span style=\"font-family:Verdana;\">77.93%)
females and 64 (22.07%) males. The mean age of the patients was 42.79 ¡À </span><span style=\"font-family:Verdana;\">15.18 years. The mean duration of symptoms was
40.80 ¡À 54.09 months. A</span><span style=\"font-family:Verdana;\">rthritis (67.24%) was the main reason for
consultation, followed by joint pain (31.38%). rheumatoid arthritis (41.03%),
unclassified chronic inflammatory rheumatic diseases (38.62%),
spondyloarthropathies (15.17%) and systemic lupus erythematosus (2.41%) were
the major clinical forms. The immunological tests performed in 13.79% of cases
were positive in 52.94% of cases. Carpitis (57.55%) and diffuse osteoporosis
(45.28%) were the commonest radiographic features of the hands. 289 patients
(99.66%) received symptomatic treatments such as NSAIDs (73.36%) and
corticosteroids (51.90%) and 90 patients (31.03%) were treated with synthetic
DMARDs such as
%K Chronic Inflammatory Rheumatic Diseases
%K Rheumatoid Arthritis
%K Spondyloarthropathies
%K Sub-Saharan Africa
%U http://www.scirp.org/journal/PaperInformation.aspx?PaperID=113997